MD BIOSCIENCES INFLAMMATIONS DISCOVERY SERVICES LTD SPIN-OUT

2 March 2005

MD Biosciences Inflammations Discovery Services (MDBIDS), the most recent spin-out company from the University of Glasgow, held an official launch on 2nd March. The new company is dedicated to providing a unique combination of discovery products and services for companies engaged in inflammation research. It is a joint venture between the University of Glasgow, and the internationally renowned bioscience services company, Morwell Diagnostics.

The new company involves close collaboration amongst highly specialised clinical consultants and top class scientific researchers in the University and is the site of several new cutting-edge models such as the T- and B- cell transfer model for predicting the potential role of new compounds in the progress and treatment of inflammatory diseases.

With the addition of the inflammations discovery service laboratory in Glasgow, the company now has access to a unique team of scientists who make up a strong global network comprising inflammation specialists, pharmaco-biologists, in vivo and in vitro laboratory personnel and project leaders.

With specialised laboratories located in Minnesota, Glasgow, and Israel, MD Bioscience’s panel of internationally recognised experts provide in-depth expertise and technologies to tackle problems and provide total solutions leading to shorter project lead times.

At the launch, Managing Director, Eddie Moradian, thanked everyone involved in the project while Sir Muir Russell, Principal of the University of Glasgow, ‘welcomed the valuable working partnership between the University and the company.’ Professor Steve Beaumont, Vice-Principal of Research & Enterprise, praised the University’s track record in commercialising research and highlighted that company formations are one of the main ways to turn the University’s world-class research into competitive market advantage for Scotland.

The launch was supported by the European Regional Development Fund and SE Glasgow through the DIALOGUES initiative.

For further information on MD Biosciences, contact:

Brian McGeough, Commercialisation Manager, Research & Enterprise

T:

E:

Or visit www.mdbiosciences.com/

For further information on DIALOGUES, contact:

T:

E:

Or visit: www.dialogues.gla.ac.uk/

Back to Latest News